Clinical Trial Update: Metamizol for the Treatment of Neoplastic Chronic Pain [Phase 4]

View source ↗

Summary

A Phase 4 trial of metamizol for cancer-related chronic pain was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Metamizol (metamizol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pain | Phase 4 | Status: TERMINATED